Skip to main content
. 2022 May 24;14(11):2596. doi: 10.3390/cancers14112596

Figure 1.

Figure 1

Mean change in left ventricular ejection fraction by visit. CL, confidence limit; ddAC, dose-dense doxorubicin plus cyclophosphamide; DPH, docetaxel, pertuzumab, and trastuzumab; FEC, fluorouracil, epirubicin, and cyclophosphamide; TPH, paclitaxel, pertuzumab, and trastuzumab.